Pd. Lilly et al., KINETIC CHARACTERIZATION OF CYP2E1 INHIBITION IN-VIVO AND IN-VITRO BYTHE CHLOROETHYLENES, Archives of toxicology, 72(10), 1998, pp. 609-621
Trans- and cis-1,2-dichloroethylene (DCE) isomers inhibit their own me
tabolism in vivo by inactivation of the metabolizing enzyme, presumabl
y the cytochrome P450 isoform, CYP2E1. In this study, we examined cyto
chrome P450 isoform-specific inhibition by three chloroethylenes, cis-
DCE, trans-DCE, and trichloroethylene (TCE), and evaluated several kin
etic mechanisms of enzyme inhibition with physiological models of inhi
bition. Trans-DCE was more potent than cis-DCE, and both were much mor
e effective than TCE in inhibiting CYP2E1. The kinetics of in vitro lo
ss of p-nitrophenol hydroxylase (pNP-OH) activity (a marker of CYP2E1)
in microsomal incubations and of the in vivo gas uptake results were
most consistent with a mechanism in which inhibition of the metabolizi
ng enzyme (CYP2E1) was presumed to be related to interaction of a reac
tive DCE metabolite with remaining substrate-bound, active CYP2E1. The
kinetics of inhibition by TCE, a weak inhibitor in vitro, were very d
ifferent from that of the dichloroethylenes. With TCE, parent compound
concentrations influenced enzyme loss. Trans-DCE was a more potent in
hibitor of CYP2E1 than cis-DCE based on both in vivo and in vitro stud
ies. Quantitative differences in the inhibitory properties of the 1,2-
DCE isomers may be due to the different stability of epoxides formed f
rom bioactivation by CYP2E1. Epoxide intermediates of DCE-metabolism,
reacting by water addition, would yield dialdehyde, a potent cross-lin
king reagent.